<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Xiao PJ</submitter><funding>NIDDK NIH HHS</funding><funding>NIAID NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>NCI NIH HHS</funding><funding>NIAMS NIH HHS</funding><pagination>309-24</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4841008</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>27(4)</volume><pubmed_abstract>Perinuclear retention of viral particles is a poorly understood phenomenon observed during many virus infections. In this study, we investigated whether perinuclear accumulation acts as a barrier to limit recombinant adeno-associated virus (rAAV) transduction. After nocodazole treatment to disrupt microtubules at microtubule-organization center (MT-MTOC) after virus entry, we observed higher rAAV transduction. To elucidate the role of MT-MTOC in rAAV infection and study its underlying mechanisms, we demonstrated that rAAV's perinuclear localization was retained by MT-MTOC with fluorescent analysis, and enhanced rAAV transduction from MT-MTOC disruption was dependent on the rAAV capsid's nuclear import signals. Interestingly, after knocking down RhoA or inhibiting its downstream effectors (ROCK and Actin), MT-MTOC disruption failed to increase rAAV transduction or nuclear entry. These data suggest that enhancement of rAAV transduction is the result of increased trafficking to the nucleus via the RhoA-ROCK-Actin pathway. Ten-fold higher rAAV transduction was also observed by disrupting MT-MTOC in brain, liver, and tumor in vivo. In summary, this study indicates that virus perinuclear accumulation at MT-MTOC is a barrier-limiting parameter for effective rAAV transduction and defines a novel defense mechanism by which host cells restrain viral invasion.</pubmed_abstract><journal>Human gene therapy</journal><pubmed_title>Disruption of Microtubules Post-Virus Entry Enhances Adeno-Associated Virus Vector Transduction.</pubmed_title><pmcid>PMC4841008</pmcid><funding_grant_id>P30 CA016086</funding_grant_id><funding_grant_id>R01 AI072176</funding_grant_id><funding_grant_id>R01DK084033</funding_grant_id><funding_grant_id>R01AR064369</funding_grant_id><funding_grant_id>P01HL112761</funding_grant_id><funding_grant_id>R01AI072176</funding_grant_id><pubmed_authors>Xiao PJ</pubmed_authors><pubmed_authors>Mitchell AM</pubmed_authors><pubmed_authors>Li C</pubmed_authors><pubmed_authors>Samulski RJ</pubmed_authors><pubmed_authors>Huang L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Disruption of Microtubules Post-Virus Entry Enhances Adeno-Associated Virus Vector Transduction.</name><description>Perinuclear retention of viral particles is a poorly understood phenomenon observed during many virus infections. In this study, we investigated whether perinuclear accumulation acts as a barrier to limit recombinant adeno-associated virus (rAAV) transduction. After nocodazole treatment to disrupt microtubules at microtubule-organization center (MT-MTOC) after virus entry, we observed higher rAAV transduction. To elucidate the role of MT-MTOC in rAAV infection and study its underlying mechanisms, we demonstrated that rAAV's perinuclear localization was retained by MT-MTOC with fluorescent analysis, and enhanced rAAV transduction from MT-MTOC disruption was dependent on the rAAV capsid's nuclear import signals. Interestingly, after knocking down RhoA or inhibiting its downstream effectors (ROCK and Actin), MT-MTOC disruption failed to increase rAAV transduction or nuclear entry. These data suggest that enhancement of rAAV transduction is the result of increased trafficking to the nucleus via the RhoA-ROCK-Actin pathway. Ten-fold higher rAAV transduction was also observed by disrupting MT-MTOC in brain, liver, and tumor in vivo. In summary, this study indicates that virus perinuclear accumulation at MT-MTOC is a barrier-limiting parameter for effective rAAV transduction and defines a novel defense mechanism by which host cells restrain viral invasion.</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Apr</publication><modification>2025-04-19T11:54:48.339Z</modification><creation>2019-03-27T02:12:11Z</creation></dates><accession>S-EPMC4841008</accession><cross_references><pubmed>26942476</pubmed><doi>10.1089/hum.2016.008</doi></cross_references></HashMap>